An administrative stage inference algorithm for use in patients receiving chemotherapy for colorectal cancer.

被引：1
|
作者：
Brooks, Gabriel A.
Landrum, Mary Beth
Keating, Nancy Lynn
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18121
引用
收藏
页数：5
相关论文
共 50 条
  • [1] The effect of gaps in chemotherapy in patients with stage IV colorectal cancer.
    Sada, Yvonne
    Davila, Jessica
    El-Serag, Hashem
    Duan, Zhigang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Unplanned delays among patients receiving FOLFOX chemotherapy for colorectal cancer.
    Kogan, Lawrence
    Jankowski, Mika
    O'Bryant, Cindy L.
    Davis, Sarah Lindsey
    Brooks, Gabriel A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] The use of dexrazoxane as a cardioprotectant in patients receiving epirubicinbased chemotherapy for metastatic breast cancer.
    Monnier, A
    Marty, M
    Espié, M
    Delozier, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 38S - 38S
  • [4] Feasibility of dignity therapy in patients with stage IV colorectal cancer receiving chemotherapy.
    Vergo, Maxwell Thomas
    Nimeiri, Halla Sayed
    Mulcahy, Mary Frances
    Von Roenn, Jamie H.
    Benson, Al Bowen
    Emanuel, Linda
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [5] RESECTION OF PRIMARY COLORECTAL CANCER PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR UNRESECTABLE STAGE IV COLORECTAL CANCER.
    Noguchi, K.
    Yamagami, H.
    Takahashi, S.
    Takahashi, M.
    [J]. DISEASES OF THE COLON & RECTUM, 2017, 60 (06) : E309 - E309
  • [6] PREDICTIVE FACTORS FOR CHEMOTHERAPY RESPONS IN PATIENTS WITH COLORECTAL CANCER.
    Omesiete, N. P.
    Cruz, A.
    Estrada, T.
    Wusterbarth, E.
    Pefok, E.
    Silva, R.
    Nfonsam, V.
    [J]. DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [7] Incidence of and risk factors for hospitalizations from chemotherapy among patients with stage III and stage IV colorectal cancer.
    Falconi, April
    Fishman, Ezra
    Barron, John
    Eleff, Michael
    Fisch, Michael Jordan
    Chi, Winnie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy
    Sunaga, T.
    Suzuki, S.
    Kogo, M.
    Kurihara, T.
    Kaji, S.
    Koike, N.
    Harada, N.
    Suzuki, M.
    Kiuchi, Y.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2014, 23 (03) : 394 - 400
  • [9] Adjuvant chemotherapy for colorectal cancer.
    Demols A.
    Van Laethem J.L.
    [J]. Current Gastroenterology Reports, 2002, 4 (5) : 420 - 426
  • [10] SURGICAL COMPLICATIONS ARE ASSOCIATED WITH OMISSION OF CHEMOTHERAPY FOR STAGE III COLORECTAL CANCER.
    Hendren, S.
    Birkmeyer, J.
    Sonnenday, C.
    Yin, H.
    Banerjee, M.
    Morris, A.
    [J]. DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 558 - 559
12345